Developing a non-invasive treatment for twin-twin transfusion syndrome
Twin-twin transfusion syndrome (TTTS) is a rare condition that can develop when identical twins share a placenta. Blood passes unevenly between the babies, which can cause serious health problems. The current standard treatment uses a tiny camera and laser inside the womb. However, this is usually only offered after 18 weeks of pregnancy and carries risks like early labour or infection. This study looks at a gentle alternative called High-Intensity Focused Ultrasound (HIFU) for women who are 12 to 17 weeks pregnant. HIFU uses targeted sound waves applied from outside the tummy to seal the connected blood vessels. Because no cuts or needles enter the womb, it may be safer for both mother and babies. Taking part involves treatment in London, an overnight hospital stay, and follow-up checks over two weeks. Travel and accommodation costs are covered for participants and a companion.
At a glance
What is this study about?
Identical twins who share a single placenta are known as monochorionic twins. In some of these pregnancies, abnormal blood vessels connect the babies to each other. This leads to twin-twin transfusion syndrome (TTTS), where one twin gives away too much blood and the other receives too much. Without treatment, TTTS can be dangerous for both babies.
The usual treatment is laser surgery, which seals the connecting blood vessels. However, this involves inserting surgical tools into the womb. Doctors usually only perform it after 18 weeks of pregnancy because doing it earlier carries high risks of miscarriage, waters breaking early, or infection. In about a quarter of TTTS cases, treatment is needed before 18 weeks, leaving parents with very few safe options.
This trial investigates High-Intensity Focused Ultrasound (HIFU) to treat TTTS between 12 and 18 weeks. HIFU works by focusing high-energy sound waves directly onto the target blood vessels from outside the body. It gently heats and closes these vessels without any cuts to the skin or entry into the womb, protecting the surrounding tissues.
Researchers have successfully tested this method in the laboratory, and this study is the first time it is being used in pregnant women. The goal is to see whether HIFU is a safe, effective, and non-invasive way to protect both babies when TTTS develops early.
Key takeaways
- Tests a non-invasive sound-wave treatment for TTTS between 12 and 18 weeks of pregnancy.
- Aims to seal shared blood vessels without needles, incisions, or instruments entering the womb.
- Treatment and early checks take place at Queen Charlotte's and Chelsea Hospital in London.
- Travel expenses and partner accommodation are fully covered by the study.
- Taking part is voluntary and does not replace your standard NHS delivery care.
Who may be eligible?
You may be able to join this study if you are at least 18 years old and pregnant with identical twins who share a placenta. Your pregnancy must be between 12 weeks and 17 weeks plus 6 days along, and you must have been diagnosed with TTTS (stages 1 to 4). Doctors must also be able to see the connecting blood vessels clearly using an ultrasound scan.
You will not be able to take part if you are 51 or older, carrying triplets or higher multiples, or if your body mass index (BMI) is over 35. You are also not eligible if one or both babies have already passed away, if you have significant scarring on your tummy, or if the ultrasound cannot clearly locate the vessels to plan the treatment safely.
Because the specialised treatment takes place at Queen Charlotte's and Chelsea Hospital in London, you must also be willing and able to travel there for your care and follow-up visits.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am pregnant with identical twins who share a single placenta.
- I am between 12 weeks and 17 weeks plus 6 days pregnant.
- My twins have been diagnosed with Twin-Twin Transfusion Syndrome (TTTS).
- I am aged between 18 and 50 years old.
- My BMI is 35 or lower.
- I am able and willing to travel to London for treatment and follow-up visits.
What does participation involve?
If you take part, you will travel to Queen Charlotte's and Chelsea Hospital in London for the HIFU procedure. You will stay overnight in hospital for monitoring, and free accommodation is provided for someone to stay with you. You will need to lie still on your back while the team uses ultrasound to guide the sound waves to the placenta.
The day after treatment, you will have a scan and a short interview with the research team. You will be given a diary to track how you feel over the next two weeks. You will then return for follow-up checks 3 days, 7 days, and 14 days after treatment. If the TTTS has not completely cleared by day 3, a second treatment may be offered. Travel expenses for all these visits are reimbursed.
After your day 14 check, you will return to your local NHS hospital for your normal pregnancy care. After your babies are born, the study team will review your birth records and get in touch 4 to 6 months after your original due date for a follow-up phone call or chat.
Potential risks and benefits
Locations (1)
- Imperial College Healthcare NHS TrustCity onlyLondon, England
Common questions
What is High-Intensity Focused Ultrasound (HIFU)?
HIFU is a treatment that uses concentrated sound waves directed through the skin to heat and seal specific blood vessels inside the body without needing cuts or surgery.
Will taking part cost me anything?
No. The trial will cover your travel expenses to London and provide free overnight accommodation for both you and a companion.
Is the treatment painful?
You may feel warmth or mild discomfort on your skin during the procedure, and lying still for a long time can feel uncomfortable. Pain relief will be provided if you need it.
Where do I have my babies if I join the study?
After your two-week study visits in London, you return to your local NHS hospital. You can give birth at your chosen local maternity unit as planned.
Can I leave the study if I change my mind?
Yes. You can withdraw from the study at any time without giving a reason. Your standard NHS maternity care will continue as normal.
How to find out more
Caroline Shaw
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.